Role of microglia in HIV-1 infection

Susceptibility to HIV-1

The presence of HIV-1 and simian immunodeficiency (SIV) virus infection increases the percentage of activated monocytes as well as monocyte/macrophage turnover in tissue [19]. According to Rappaport et al., migration of the CD14+CD16+monocytes subpopulation, which is highly susceptible to HIV-1 infection, through the BBB into the CNS is essential in the pathogenesis of HAND [20].

Not only does HIV-1 require the presence of CD4 to enter CNS cells, but it also requires the presence of chemokine receptor type 4 (CXCR4) or CC-chemokine receptor (CCR) 5 co-receptors and CCR3 receptors to generate valid infections. It is worth noting that CCR5 is strongly linked to viral invasion and the progression of neurological diseases. CCR3 and CCR5 expression is detected on the surface of microglial cells, making them more susceptible to HIV-1 infection [21].

HIV-1 has been shown to infiltrate macrophages and microglia through CD4 mediation. Microglia infection is thought to be produced by infected mononuclear cell transmigration, which appears early in infections. In recent years, a subgroup of infected mononuclear cells, HIV+, CD14+, and CD16+ mononuclear cells, has been discovered to prefer penetrating the blood–brain barrier (BBB) [22]. The cells described above express junction proteins [e.g., activated leukocyte cell adhesion molecule (ALCAM), junctional adhesion molecule-A (JAM-A), and CCR2] that help them penetrate the BBB. However, those infected mononuclear cells might infect microglia.

On the other hand, Microglia may ingest infected CD4+ T cells that migrate to the cerebrum [23]. Although not demonstrated, this later causal connection may be more likely to promote viral proliferation than free virus exposure [24]. Regardless of the infection mechanism, cerebral microglia appear to be susceptible to HIV-1 infection. Infection happens in microglia even with the high expression level of cell restrict factor SAMHD1 [Sterile alpha motif (SAM) domain and histidine–aspartate (HD) domain 1] [25], which is probably attributed to its phosphorylation by cyclin-dependent kinase 1 (CDK1), that occurs in cells cycling between G0 and G1 status [26].

Microglia have been discovered to be susceptible to HIV-1 infection both in vitro and in vivo [27]. Cosenza et al. and Churchill et al. identified HIV-1 proteins, DNA, and RNA in microglia from autopsy tissues from HIV-1 patients, though it should be noted that the patients in question died from severe HAND [28, 29]. According to a new study, microglial cells were subjected in patients with suppressed virus levels who died of causes unrelated to HIV-1 [30]. The study employed a cohort of 16 patients on ART with confirmed long-term HIV-1 control from the National Neuro AIDS Tissue Consortium (NTTC). The researchers employed the high-specificity technique to identify and measure DNA and RNA of HIV-1 at the cell level. As revealed from the outcomes, perivascular macrophages and microglial cells had HIV-1 DNA, other than stellate cells. When HIV-1 RNA was not detected in cerebrospinal fluid (CSF) or blood, the researchers observed HIV-1 RNA in the described cells in 6 of 16 individuals, showing that viruses might be produced in the CNS.

Besides, as previous research has shown, microglia are prone to infections in vitro. Certain in vitro models of infection-prone human microglial cells have been developed [31,32,33,34,35]. Moreover, a few latency models based on the aforementioned models have been created and have proven to be useful tools for investigating the infection process and molecule-level causal connections underlying the prevalence and treatment of latent HIV-1 in microglial cells [21, 36]. It has been proven that viruses were discovered in the CSF of subjects on effective ART with non-detectable plasmatic HIV-1, implying that HIV-1 may also be generated in the cerebrum [37, 38].

Main HIV-1 reservoir in the brain

The following are the standards for cellular reservoirs: (i) the identification of integrated DNA of HIV-1 in the host genome of long-life cells, (ii) the identification of causal links allowing the viruses to persistently exist in cellular reservoirs, including the causal links capable of establishing and maintaining a hidden infection, and (iii) forming of duplication-competent particulates after the stimulation of reservoirs [39]. Additionally, two criteria for a real reservoir have been presented in microglia, such as the detection of integrated HIV-1 DNA within long-life cells and the identification of causal links allowing the viruses to remain in cellular reservoirs [40]. Furthermore, due to ethical and technological obstacles, it is not possible to investigate whether microglia are capable of producing replication-competent viruses in humans.

Meanwhile, using immunohistochemistry and the new, highly sensitive in situ hybridization methods RNAscope and DNAscope, researchers detected HIV-1 in cerebral macrophages and microglia rather than astrocytes [30]. Additionally, the infection is believed to be unproductive. As a result, they may not serve as real HIV-1 reservoirs [41]. In contrast, it has been revealed that macrophages and microglia are susceptible to HIV-1 infection and assist a valid infection [27]. As aforesaid, the valid infection in microglia within the CNS is correlated with HAND in humans and animals (e.g., the macaques) [7]. For this reason, macrophages and microglia can be considered true reservoirs in the cerebrum.

Microglia are generated in the yolk sac from erythromyeloid progenitors and penetrate the developing CNS during the embryogenetic process [42]. On that basis, they are the predominant resident cells in the cerebrum that can function as cerebral macrophages. Due to their long half-life of years, they have a stable population [43]. In contrast to macrophages, they are capable of cellular division, allowing HIV-1 to survive in the cerebrum [44]. Moreover, according to a recent study, microglia are extremely sensitive to the HIV-1 virus [45]. Generally, the microglia may form one of the primary HIV-1 reservoirs in the cerebrum.

Promotion of neuroinflammation

Microglia are long-lived cells that induce immunological responses, allowing peripheral immunocytes to penetrate the CNS and maintaining CNS homeostasis [46]. They may be the critical cells to initiate and sustain positive feedback loops of persistent inflammatory events within the CNS.

When microglial cells are activated, they undergo functional, morphological, and phenotypic changes, and in vivo positron emission tomography (PET) image formation has established the role of microglia stimulation in the HIV-1 infection process [47, 48]. Once microglia are stimulated, genetic expression variations induce facilitated growth and variations in cell signaling (e.g., the production and release of pro-inflammation cell factors, chemotactic factors, and effector molecules) [49, 50]. The release of the above-mentioned molecules [e.g., matrix metalloproteinases (MMPs) and ROS) directly damages nerve cells, resulting in neuronal function loss and neurotoxic effects [51, 52], which eventually facilitates microglia stimulation. Furthermore, virally induced chemokine secretion [e.g., CCL2 (C–C motif chemokine ligand 2)] promotes the dissemination of chronic inflammatory events [53,54,55,56]. CCL2 stimulates microglial cells, regulates their migratory activities, and facilitates self-proliferative activities [57] while recruiting peripheral macrophages and T cells to the CNS. More immune-mediated damage, microglia stimulation, and the recruitment of immune cells are induced by these cells.

As revealed from recent findings, HIV-1 infection is capable of creating inflammation surroundings induced by virus proteins [transactivator of transcription (Tat) and gp (glycoprotein) 120] and pro-inflammation cell factors [tumor necrosis factor-alpha (TNF-α), interleukin (IL)-8, IL-6, and IL-1β] [58, 59]. The HIV-1 Tat protein can stimulate the NLR and upregulate caspase-1 and IL-1β levels in microglial cells, resulting in the production of IL-6 and TNF-α, and the intensification of pro-inflammatory response [60]. Microarray analyses were conducted by adopting cerebrum specimens from HIVE sufferers, HIV/noE, and HIV-controls. Significant microglial genes (e.g., immunity activation and functions, kinases, phosphatases, and pro-/anti-apoptosis and neurotrophy factors) were found to undergo remarkable changes during the process of HIV-1 infections, demonstrating that microglial functions are damaged and exhibit a proinflammation trend [50]. Nevertheless, the specific mechanisms of HIV-1-associated chronic neuroinflammation should be studied further because they may be influenced by specific infectious pathogens as well as the subsequent immune response.

Acceleration of brain aging

Inflammatory microglia are likely to trigger or speed up cerebral aging via the interference with the physiology repairment and restoration process [61]. HIV-1, in particular, infects microglia, causing severe neuroinflammation and neuronal death if left untreated, culminating in brain structure and function loss [62,63,64].

First, after being infected with HIV-1, microglia's ability to fight infection, and also their ability to repair and regenerate, may be impaired [65]. Secondly, microglia may generate excessive neurotoxic factors such as oxygen free radicals (ROS) (e.g., arachidonic acid, quinolinic acid, and nitric oxide) [66]. It has been found that ROS is associated with neuronal cell death, neuroinflammation, and corresponding neurodegeneration, all of which accelerate brain aging [67,68,69]. For this reason, HIV-1 infection of the nervous system can accelerate brain aging by triggering neurotoxic immune responses in microglia. Thirdly, infection-related cytokines may become uncontrolled, and inflammatory cytokines will take over, causing pathological damage, inhibiting regeneration and repair, and interfering with brain physiological functions. The relevant destructive factors consist of IL-17A [70,71,72,73,74] and TNF-α [75]. Specifically, IL-17A is a marker of a key T helper cell population implicated in the pathogenesis of autoimmune and degenerative disorders. The role of IL-17A has been shown to be varied, as it not only contributes to pathogenic inflammation but also supports innate-like acute immune responses, and it is widely accepted that IL-17A causes diseases by activating glial cells. During inflammatory conditions, BBB endothelial cells express tumor necrosis factor superfamily (TNFSF) receptors and interact with TNFSF ligands in soluble form as well as on invading immune cells. TNFSF receptors and ligands are also found on CNS-invading effector immune cells as well as CNS-resident cells. Hence, this receptor-ligand interaction has a significant influence on the outcome of neuroinflammatory disease. Inflammatory cytokines may be generated locally in the brain, while HIV-1 infection may cause peripheral inflammatory cytokine to be overproduced, i.e., cytokine storm, and released into the bloodstream, affecting the BBB and the entire brain [76]. Fourthly, HIV-1 may remain in the brain for a period of time, resulting in a persistent low-grade inflammatory response. Taber et al. discovered that HIV-1 infection increased microglial activation in the hippocampus and neocortex through an analysis of autopsy reports from chronically HIV-1-infected patients, demonstrating that HIV-1-associated chronic neuroinflammatory responses may result in decreased neurons as well as neuronal cell death [77]. On the other hand, chronic HIV-1 infection causes neuroinflammation as well as microglial activation [78]. There is also mounting evidence supporting the production and deposition of β-amyloid-like peptides, which are comparable to those found in Alzheimer’s disease [79, 80]. All of the conditions mentioned above can have a long-term impact on microglial function, resulting in chronic low-grade inflammation or dysfunctional microglia, which reduces brain regeneration and remodeling.

Microglia are also affected by the elevated systemic inflammatory immunological state, which results in decreased physiological neuroregeneration and remodeling [81, 82]. Inflammation is undoubtedly enhanced and exacerbated by recurring or chronic HIV-1 infections [83]. An elevated and persistent inflammatory state in the brain may cause neurodegeneration owing to enhanced neuronal cell death and reduced neurogenesis, impaired remodeling, and permanent neural network injuries, thus worsening or hastening brain aging [61]. Moreover, since the information on the cellular and molecular pathways through which microglia accelerate brain aging is limited, further study is needed in the future.

Contribution to HAND

Microglia, one of the resident members of the mononuclear phagocytic family in the CNS, are evenly distributed in the CNS parenchyma and are crucial in maintaining the homeostasis and health of the CNS, anti-inflammatory and resisting pathogen invasion. Hence, one of the pathways leading to HAND is the reduction of microglia caused by HIV-1 infection and injury [84]. In addition, viral proteins, cytokines, and chemokines produced after microglia infection are the main factors that indirectly cause neuronal apoptosis. However, the etiopathogenesis of HAND remains elusive, whereas it is attributed to multiple factors (i.e., ART neurotoxic effects, HIV-1 duplication within the CNS from infected cellular reservoirs, CNS inflammatory events, Ca aberrant regulation, mitochondrion function disorder, drug abuse, as well as autophagy) [78].

HIV-1-related proteins include the structural protein gp120, as well as regulatory proteins such as Tat, viral protein R (Vpr), and negative regulatory factor (Nef). gp120 mainly comes from the secretion of infected microglia and virion shedding and can induce the production of TNF-α, IL-1β, IL-6, macrophage colony-stimulating factor (GM-CSF), ROS, etc., thus directly or indirectly causing neuronal apoptosis [61]. As a regulatory protein of HIV-1, Tat can promote the replication initiation and elongation of HIV-1 DNA. Meanwhile, Tat, as a transactivator, can control gene expression in infected and non-infected cells. In HAND, Tat has cytotoxic and pro-inflammatory effects, and HIV-1 Tat protein can enhance microglial K+ efflux, Ca2+ influx, upregulate cytokine and chemokine levels, etc.[60] Vpr has been demonstrated to induce neuronal apoptosis, cell cycle arrest, transcriptional activation of viral promoters, nuclear translocation of pre-integrated complexes, and apoptosis in infected cells during the G2 phase [85].

Besides, microglia can express HIV-1 co-receptors such as CXCR4 and CCR5, both of which are members of the G protein-coupled receptor family, and complete signal transduction via the G protein signaling system. After the receptors are activated by HIV-1 or related proteins, a large amount of intracellular Ca2+ influx induces the formation of intracellular free radicals, damages cells, and causes apoptosis. Activated microglia can also secrete pro-inflammatory factors, including TNF-α, IL-1β, monocyte chemoattractant protein-1 (MCP-1), chemokines, and NO [86]. These inflammatory substances can up-regulate p38 MAP kinase, phosphorylate apoptosis-related transcription factors, and induce microglial apoptosis [87]. Additionally, positive feedback can activate more microglia and release a series of neurotoxic substances and more cytokines, resulting in a wider range of neuronal damage.

Furthermore, microglia can release excitatory neurotoxins such as quinolinic acid, glutamate, L-cysteine, and arachidonic acid. Excessive glutamate causes over-activation of glutamate receptors on nerve cell membranes, mainly N-methyl D-aspartate (NMDA), Ca2+ influx, the release of oxidative stress substances and toxic lipids such as 4-hydroxynonenal and ceramides, and activation of intracellular apoptotic pathways, thereby causing neuronal apoptosis [88]. The release of neurotoxins can stimulate astrocytes and microglia to release excitatory amino acids, resulting in positive feedback.

Although most HIV-1 infected individuals are primarily asymptomatic, the virus can co-exist with immunity activation of the CNS/cerebrospinal fluid [89,90,91]. Latent or active HIV-1 can cause neurocognitive impairment. HAND is classified into three categories according to the degree of the dysfunction: 1) asymptomatic neurocognitive impairment (ANI), 2) mild neurocognitive impairment (MND), and 3) HIV-associated dementia (HAD). HAD is the most severe variant of HAND, characterized by severe dementia shown by a lack of concentration, apparent motor faults, and unstable behavior changes [88]. HAND remains an unresolved multifactor aggravating HIV-1 disease. According to recent research, except for inhibiting HIV-1 duplication within the CNS, no clinical trials of HAND treatment might be effective [92, 93]. Nevertheless, certain studies reported a decrease in cognition damage as impacted by ART, i.e., sufferers with a regulated virus load who discontinued antiretroviral therapies have reported improved cognitive functions and mitigated neuronal damage [93, 94].

In summary, excessive activation and/or persistent stimulation of microglial cells, as well as overproduction of inflammatory mediators, may result in neurotoxicity [17]. Microglia are capable of generating neurocognitive degeneration (e.g., different forms of HAND), thereby increasing pro-inflammation chemotactic factors and cell factors along with neurotoxins, which adversely influence stellate cells and nerve cells and induce neural injury [18].

留言 (0)

沒有登入
gif